In this WHO 4 subset group, sabizabulin treatment resulted in statistically and clinically significant reductions in mortality as well as days in the ICU, on mechanical ventilation, and in the hospital. Whether online, through your practice management system, vendor or direct through a data feed, EDI ensures that your claims get submitted quickly. Llame al 1-855-464-3571 (Los Angeles), 1-855-464-3572 (San Diego) (TTY: TTY: 711). Health Net Life is soliciting to sell health insurance. ET to discuss its fiscal 2022 fourth quarter and full year ended September 30, 2022 financial results and provide a business update. To be eligible for a Health New England Medicare Supplement plan, you must live within the state of Massachusetts, be entitled to Medicare Part A (hospital insurance), be enrolled in Medicare Part B (medical insurance) and continue to pay your Medicare Part B premiums. Activate your myCigna account for access to all plan details and live, 24/7 support. A claim cannot be submitted without the required fields completed. Health Net is a registered service mark of Health Net, LLC. First, you will need to fill out the claim form below. Patients were randomized (2:1) to sabizabulin 9 mg or placebo oral daily dose (up to 21 days or discharge from hospital). Please provide as much information as possible. Enroll during your Medicare Enrollment period, beginning three months before you turn age 65 and ending three months after you turn age 65 to be guaranteed issue. Supplemental Health Claim Form For the latest in COVID-19 coverage, vaccine, and frequently asked questions, Center Supplemental Health Claim Form File an accidental injury, critical illness, hospital care, or wellness claim. Get Your Free Medicare Informational Kit Plan Information: Fill out the form below, email us at msupport@hne.com or call us from at 8 a.m. - 8 p.m. / 7 days a week at (413) 787-0010 (TTY: 711) or toll free at (877) 443-3314 Learn more about the data we collect or request your data be removed. Health New England One Monarch Place, Suite 1500 Springfield, MA 01144-1500 Member Services (local): (413) 787-4004Contact Us - Health New England The Industrial School question, as our readers are aware, was made a matter of inquiry by Messrs Strode and . By continuing to use our site, you agree to our Privacy Policy and Terms of Use. We are sorry for any issues this may cause. Medicare Supplement. Offering your clients a Medicare Supplement plan can help them for pay for: Copayments. $18.37 - $33.98 Full-time, Part-time Portland, ME 04122 Urgently Hiring Apply Now AAA Northern New England Life Sales . Bin 017010 cimcare 11-A1 BIN Number 004336, 610591 610084, 021007 020107, 020396 M 12-A2 Version/Release Number D M NCPDP vD. Each link will open a new window and is either a PDF or a website. You will need Adobe Reader to open PDFs on this site. Planned Phase 2b study of zuclomiphene citrate to treat hot flashes in men with advanced prostate cancer undergoing androgen deprivation therapy. Note: Medicare Supplement Policy Descriptions will be available for download shortly. Call 1-855-464-3571 (Los Angeles), 1-855-464-3572 (San Diego) (TTY: TTY: 711). Member Services Health Net Life Medicare Supplement (Medi-Gap) 1-800-926-4178 TTY: 711, Health Net collects some private data about site visitors. Download the free version of Adobe Reader. That is why we are sharing this Health and Wellness Guide with you. New York and New Jersey Residents Only: The salary range for New York City, NY and Westchester County, NY is $34,730 - $60,360. As a Medicare health plan, Health New England Medicare Advantage covers all services required by Original Medicare. In a post hoc subset analysis, in COVID-19 patients who had at least one comorbidity and required supplemental oxygen, the baseline characteristics were similar between the sabizabulin and placebo groups. . Most individual physicians may automatically register online and can log in to begin working on a case within minutes. With our online information about claims procedures, we've put an end to heavy manuals to page through. The Company has completed a positive Phase 3 COVID-19 study evaluating sabizabulin in hospitalized moderate to severe COVID-19 patients at high risk for ARDS. Click the Next button at the bottom of each page to save your information. Enrolling Phase 3 ENABLAR-2 study of enobosarm + abemaciclib (a CDK 4/6 inhibitor) combination in AR+ ER+ HER2- metastatic breast cancer with AR 40% expression (second-line metastatic setting). This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. The UKs Medicines and Healthcare Products Regulatory Agency (MHRA) informed the Company on July 25, 2022, that the sabizabulin marketing authorization application will receive expedited review. Below are a list of forms for Health New England Medicare Advantage members. Medicare Supplement plans provide coverage for: * Medicare Part A deductible of$1,556 is covered under Plans F, Innovative Plan F, High Deductible Plan F, G,High Deductible Plan G and Innovative Plan G. A caring professional will listen carefully to your concerns and give you information to help you choose the care that's right for you. Sabizabulins mechanism of action, both in blunting the inflammatory response and preventing viral replication at the host level, could be a really important tool in our fight against COVID-19, especially given sabizabulins ability to work in COVID-19 variants of concern. The Company disclaims any intent or obligation to update these forward-looking statements. NGL's Medicare Supplement plan provides additional coverage to your client's already existing Medicare plan. MIAMI, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related dise Get access to exclusive reports Planned Phase 2b study of sabizabulin in AR+ ER+ HER2- metastatic breast cancer with AR < 40% expression (third-line metastatic setting). Medicare supplement plans typically do not cover long-term care, vision, dental, hearing aids, eyeglasses, or private nursing. Interpretation services are also available for your call. The primary endpoint was all-cause mortality up to day 60. Medicare Supplement insurance helps pay some of the health care costs (or "gaps") that are not covered by Original Medicare, such as copays, coinsurance, and deductibles. You are considered "newly eligible" if you: This site contains various Health Net Life links and resources. In the last step, youll be able to review and print all the information youve provided. Need to Submit a Claim? Medicare beneficiaries may also enroll in Bridgeway Health Solutions through the CMS Medicare Online Enrollment Center located at http://www.medicare.gov. MIAMI, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced data from the late-breaker oral presentation of the Phase 3 trial of sabizabulin treatment for hospitalized adults with COVID-19 who required supplemental oxygen at IDWeek (Infectious Disease Week) 2022, which too Veru to Present Late-Breaker Oral Presentation of Sabizabulin Treatment for Hospitalized Adults with COVID-19 on Supplemental Oxygen at Infectious Disease Week 2022 Health Net is contracted with Medicare for HMO, HMO SNP and PPO plans, and with some state Medicaid programs. 1-800-MEDICARE ( 1-800-633-4227) TTY users can call 1-877-486-2048. All Rights Reserved, ( 6 or more alphabetic and numerical characters ), Get financial insights straight to your inbox. Health (9 days ago) People also askHow do I contact the Massachusetts Department of Public Health?How do I contact the Massachusetts Department of Public Health?Contact Information. Medicare Supplement plans are designed to help fill in the gaps from Original Medicare. Copyright 2017 ResearchPool. With Teladoc, you can request a phone, mobile app or online video consultation with a Teladoc physician to treat non-emergency medical issues such as colds and the flu, bronchitis, allergies, rashes and more. Utilizing sabizabulin in WHO Class 4 patients may help prevent progression of disease, filling a gap in care in our hospitalized patients, said Paula Skarda, M.D. If so, please click on the link we sent you via email. If you would prefer to apply by phone, make sure you're signed in to your NEA Member Benefits account and call the NEA Retiree Health Program hotline at 1-844-213-1556. Access CCHCS Claims Information at CorrectCare (CCIH). Initial Decisions, Appeals, and Grievances: Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (LINA) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (NYLGICNY) (New York, NY), formerly known as Cigna Life Insurance Company of New York. Key secondary endpoints were days in intensive care unit (ICU), on mechanical ventilation, and in hospital. A randomized, multicenter placebo-controlled Phase 3 clinical trial was conducted in hospitalized moderate to severe COVID-19 patients who are at high risk for acute respiratory distress syndrome (ARDS) and death. Learn More > Thank you for your patience. Medicare Supplement insurance helps pay some of the health care costs (or "gaps") that are not covered by Original Medicare, such as copays, coinsurance, and deductibles. E-mail us at: msupport@hne.com Please Note: This is not a secure e-mail link; please don't use it for confidential correspondence. You can now get what you need without thumbing through volumes. Enrolling Phase 2 dose-finding study of VERU-100 in advanced hormone sensitive prostate cancer. For the latest in COVID-19 coverage, vaccine, and frequently asked questions, visit our Coronavirus Resource Center. Please contact the plan for further details. Internal Medicine/Pediatrics Regions Hospital, St. Paul, Minnesota, a lead investigator in Verus Phase 2 and Phase 3 clinical trials of sabizabulin. On July 6, 2022, the Company announced the publication of the Phase 3 COVID-19 trial results evaluating the efficacy and safety of oral sabizabulin in The New England Journal of Medicine Evidence. The Formulary, pharmacy network, and/or provider network may change at any time. NGLWeb2020, Copyright 2022 by National Guardian Life Insurance Company. If you're looking for a plan that covers your deductibles, copayments, coinsurance and care you receive outside of the United States, a Medicare Supplement plan may be right for you. Samuel FischExecutive Director, Investor Relations and Corporate CommunicationsEmail: To request access to management, click here to engage with our partner Phoenix-IR's CorporateAccessNetwork.com. Medi-Cal & Cal Medi-Connect Enhanced Care Management (ECM) & Community Service Billing (CS) billing procedures for all Providers. Member Services Email: memberservices@hne.com Write us a note: Compose Message Based on a planned interim analysis of the first 150 patients randomized, the Independent Data Monitoring Committee unanimously halted the study for clear clinical efficacy and no safety concerns were identified. We only make mid-year benefit changes when Medicare changes its coverage rules. Owners use Table A and Renters use Table B. You can also request a password reset or a new activation email using the links below. California member claims should be submitted to: The View Claims Details Online section of the site contains related features as well as information about patient history, copayments, physicians of record, plan summaries, and more. ATENCIN: si habla espaol, tiene a su disposicin servicios gratuitos de asistencia lingstica. report is restricted to a specific region or investor type. Sales Specialist Est. Health Net's Electronic Data Interchange (EDI) solutions make it easy for more than 125,000 in our national provider network to submit claims electronically. U.S. FDA reviewing EUA application for sabizabulin to treat hospitalized COVID-19 patients at high risk for ARDS European Medicines Agencys (EMA) Emergency Task Force reviewing sabizabulin for emergency use in EU member states Sabizabulin also under review for potential emergency authorization by MHRA (UK), TGA (Australia), and Health Canada Veru preparing for U.S. and international commercialization and distribution of sabizabulin, and manufacturing capacity for drug supply in place Company to host conference call Veru to Report Fiscal 2022 Fourth Quarter and Full Year Financial Results on December 5, 2022 Commercial sexual health program, Urev, has 2 FDA approved products: Forward-Looking StatementsThe statements in this release that are not historical facts are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Find the right contact info for the help you need. Learn about the medical, dental, pharmacy, behavioral, and voluntary benefits your employer may offer. Each claim summary includes the claim number, date of claim, patient ID number, patient name, billed amount, paid amount, claim status, and a link to HIPAA Status codes and other details. DHA Address. Details. This combination of email and password didn't match our records. These forward-looking statements are based on the Companys current expectations and subject to risks and uncertainties that may cause actual results to differ materially, including unanticipated developments in and risks related to: the development of the Companys product portfolio and the results of clinical studies possibly being unsuccessful or insufficient to meet applicable regulatory standards or warrant continued development; the ability to enroll sufficient numbers of subjects in clinical studies and the ability to enroll subjects in accordance with planned schedules; the ability to fund planned clinical development; the timing of any submission to the FDA and any determinations made by the FDA or any other regulatory authority; the possibility that as vaccines become widely distributed the need for new COVID-19 treatment candidates may be reduced or eliminated; government entities possibly taking actions that directly or indirectly have the effect of limiting opportunities for sabizabulin as a COVID-19 treatment, including favoring other treatment alternatives or imposing price controls on COVID-19 treatments; the Companys existing products and any future products, if approved, possibly not being commercially successful; the effects of the COVID-19 pandemic and measures to address the pandemic on the Companys clinical studies, supply chain and other third-party providers, commercial efforts, and business development operations; the ability of the Company to obtain sufficient financing on acceptable terms when needed to fund development and operations; demand for, market acceptance of, and competition against any of the Companys products or product candidates; new or existing competitors with greater resources and capabilities and new competitive product approvals and/or introductions; changes in regulatory practices or policies or government-driven healthcare reform efforts, including pricing pressures and insurance coverage and reimbursement changes; the Companys ability to successfully commercialize any of its products, if approved; risks relating to the Company's development of its own dedicated direct to patient telemedicine and telepharmacy services platform, including the Company's lack of experience in developing such a platform, potential regulatory complexity, and development costs; the Companys ability to protect and enforce its intellectual property; the potential that delays in orders or shipments under government tenders or the Companys U.S. prescription business could cause significant quarter-to-quarter variations in the Companys operating results and adversely affect its net revenues and gross profit; the Companys reliance on its international partners and on the level of spending by country governments, global donors and other public health organizations in the global public sector; the concentration of accounts receivable with our largest customers and the collection of those receivables; the Companys production capacity, efficiency and supply constraints and interruptions, including potential disruption of production at the Companys and third party manufacturing facilities and/or of the Companys ability to timely supply product due to labor unrest or strikes, labor shortages, raw material shortages, physical damage to the Companys and third party facilities, COVID-19 (including the impact of COVID-19 on suppliers of key raw materials), product testing, transportation delays or regulatory actions; costs and other effects of litigation, including product liability claims; the Companys ability to identify, successfully negotiate and complete suitable acquisitions or other strategic initiatives; the Companys ability to successfully integrate acquired businesses, technologies or products; and other risks detailed from time to time in the Companys press releases, shareholder communications and Securities and Exchange Commission filings, including the Companys Form 10-K for the fiscal year ended September 30, 2021 and subsequent quarterly reports on Form 10-Q. This information is not a complete description of benefits. Health New England members have access to U.S. board-certified physicians 24/7/365 through Teladoc . You will receive notice when necessary. Internal Medicine/Pediatrics Regions Hospital, St. Paul, MinnesotaSession Title: COVID-19 Late Breaking Abstracts Presentation Date and Time: Friday October 21, 2022 | 2:05 PM 2:15 PM ETPresentation Location: 209 ABC. All fields are required unless marked optional. It is a form of risk management, primarily used to hedge against the risk of a contingent or uncertain loss.. An entity which provides insurance is known as an insurer, insurance company, insurance carrier, or . . About Medicare Supplement. To access this information, register now. The Health Net Medicare Supplement plan is underwritten by Health Net Life Insurance Company. Medicare Supplement plans may cover some or all of your out-of-pocket costs, which may include your Part A and Part B deductibles and 20% coinsurance. For costs and details of coverage, review your plan documents or contact a Cigna representative. National Guardian Life Insurance Company is not affiliated with The Guardian Life Insurance Company of America a.k.a. Cigna may not control the content or links of non-Cigna websites. Health Net Life is not connected with or endorsed by the U.S. Government or the Federal Medicare program. Schedule a free consultation with one of Health Net's EDI experts. Health Net Life complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. Product availability may vary by location and plan type and is subject to change. MIAMI, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused on developing novel medicines for COVID-19 and other viral ARDS-related diseases and for oncology, today announced it will host a conference call and audio webcast on Monday, December 5, 2022, at 8:00 a.m. Non-participating providers, view claims procedures. To view claim status by member, claim number, date of service, or provider tax identification (ID) number, simply log in and follow the prompts within the Claims Details section. Presentation Details:Presentation Title: (LB1530) Clinical Benefit of Oral sabizabulin for Hospitalized Adults with CoVID-19 on Supplemental Oxygen Abstract Number: 1329811Presenter: Paula Skarda, M.D. Lilly is supplying Verzenio. The audio webcast will be accessible under Investor Kit Veru Provides Update on FDA Advisory Committee Meeting Regarding Emergency Use Authorization of Sabizabulin to Treat Hospitalized COVID-19 Patients at High Risk for Acute Respiratory Distress Syndrome Choosing Who Can See My Confidential Medical Information. SATURDAY, NOVEMBER 20, 1880. Enrollment in Health Net depends on contract renewal. Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Enrolling Phase 3 VERACITY study in metastatic castration and androgen receptor targeting agent resistant prostate cancer prior to IV chemotherapy. Health Net is working hard to make claims procedures easier for providers, both online and offline. In a planned interim analysis, sabizabulin treatment resulted in a 55.2% relative reduction in mortality compared to placebo. region or investor type. FDA has informed the Company that FDAs Pulmonary-Allergy Drugs Advisory Committee will meet on November 09, 2022, to discuss the Companys sabizabulin for COVID-19 request for emergency use authorization. The salary . We were unable to load the claim form, please try again later. WellCare will be performing maintenance on Saturday, June 11th (From 11 PM CST to 5 AM CST the next day). The only two subjects of general public interest touched upon at the late Anglican Synod were the religious teaching at the Industrial School and the question of Bible-reading in public schools. A double-blind, randomized, placebo-controlled Phase 3 COVID-19 clinical trial was conducted in 204 hospitalized COVID-19 patients with moderate to severe COVID-19 ( WHO 4-supplemental oxygen) at high risk for ARDS and death. Get access to exclusive reports of financial research, this report is restricted to a specific They created a program called Celebrating 65 that helps individuals as they get ready to retire. Health Net's Electronic Data Interchange (EDI), Contracted providers log in to access more procedures, Send us your claims question securely online, California Correctional Health Care Services (CCHCS). by answering the questions below. Forward-looking statements in this release include statements regarding: whether and when the Company will receive an emergency use authorization or any approval from FDA or from any regulatory authority outside the U.S. for sabizabulin for certain COVID-19 patients; whether and when sabizabulin will become an available treatment option for certain COVID-19 patients in the U.S. or anywhere outside the U.S.; the timing, scope and outcome of the planned advisory committee meeting; whether the Company will have sufficient supply of sabizabulin to meet demand, if an emergency use authorization or other approval is granted in the U.S. or in any other country; whether the Company will secure any advance purchase agreement with the U.S. government or any foreign government; whether the current and future clinical development and results will demonstrate sufficient efficacy and safety and potential benefits to secure FDA approval of the Companys drug candidates and companion diagnostic; whether the drug candidates will be approved for the targeted line of therapy; the anticipated design and scope of clinical studies and FDA acceptance of such design and scope; whether any regulatory pathways, including the accelerated Fast Track designations, to seek FDA approval for sabizabulin, enobosarm or any of the Companys drug candidates are or continue to be available; whether the expected commencement and timing of the Companys clinical studies, including the Phase 3 ENABLAR-2 study, the sabizabulin monotherapy Phase 2b clinical study for 3rd line treatment of metastatic breast cancer, the Phase 2 registration clinical study for VERU-100, and the development of the companion diagnostic will be met; when clinical results from the ongoing clinical studies will be available, whether sabizabulin, enobosarm, VERU-100, zuclomiphene, and ENTADFI will serve any unmet need or, what dosage, if any, might be approved for use in the U.S. or elsewhere, and also statements about the potential, timing and efficacy of the rest of the Companys development pipeline, and the timing of the Companys submissions to FDA and FDAs review of all such submissions; whether any of the selective clinical properties previously observed in clinical studies of sabizabulin, enobosarm, VERU-100 or other drug candidates will be replicated in the current and planned clinical development program for such drug candidates and whether any such properties will be recognized by the FDA in any potential approvals and labeling; whether the companion diagnostic for enobosarm will be developed successfully or be approved by the FDA for use; and whether and when ENTADFI will be commercialized successfully. ENTADFI (finasteride and tadalafil) capsules for oral use, a new treatment for benign prostatic hyperplasia. Current studies on the two drugs include: Verus late-stage prostate cancer portfolio comprises sabizabulin, VERU-100, a long-acting GnRH antagonist, and zuclomiphene citrate, an oral nonsteroidal estrogen receptor agonist. Need help beyond what's on Medicare.gov? A pension may be a "defined benefit plan", where a fixed sum is paid regularly to a person, or a "defined contribution plan", under . Verzenio is a registered trademark of Eli Lilly and Company, NEJM Evidence is a registered trademark of the Massachusetts Medical Society. A Message from President and CEO, Richard Swift: Health New England Supports Reproductive Rights At-Home Tests: Health New England is reviewing all state and federal guidance related to coverage for over-the-counter at-home COVID-19 tests starting January 15, 2022.We are working on how to implement this requirement and more information will follow. A Medicare Supplement plan (also called a Medigap policy) is private health insurance designed to supplement Original Medicare coverage. ATTENTION: If you speak Spanish or Navajo, language assistance services, free of charge, are available to you. Here's where you'll find claims information for providers in all of Health Net's service areas. All Medicare Supplement plans must . Copyright 2022 Health Net of California, Inc., Health Net Life Insurance Company, and Health Net Community Solutions, Inc. (Health Net) are subsidiaries of Health Net, LLC. Learn More > Behavioral Health We're here to provide education and support to members experiencing mental health or substance abuse issues. On August 22, 2022, Australias Therapeutic Goods Administration (TGA) determined that sabizabulin treatment in hospitalized COVID-19 patients at high risk for ARDS qualifies for an expedited, provisional registration regulatory pathway. Offering your clients a Medicare Supplement plan can help them for pay for: Visit the NGL Admin Portal for more information on Medicare Supplement for contracted agents. All Medicare Supplement plans must follow federal and state laws. The Guardian or Guardian Life. Billing and Reimbursement Provider Manual Billing & Reimbursement Information on claims submission and reimbursement, coordination of benefits and subrogation, serious reportable events and never events. Health Net Life Insurance Company holds a Certificate of Authority in California and 48 other jurisdictions throughout the UnitedStates. Each claim summary includes the claim number, date of claim, patient ID number, patient name, billed amount, paid amount, claim status, and a link to HIPAA Status codes and other details. NGLs Medicare Supplement plan provides additional coverage to your clients already existing Medicare plan. Health New England Medicare Advantage also offers various tools and clinical programs designed to help our members stay healthy, seek care, manage complex health conditions and manage medications. The Otago Daily Times. If Commercial claims are submitted for groups that have transitioned with the old BIN or PCN , claims will reject with NCPDP Reject Code 01 (M/I BIN) and 04 (M/I Processor Control Number ). A pension (/ p n n /, from Latin pensi, "payment") is a fund into which a sum of money is added during an employee's employment years and from which payments are drawn to support the person's retirement from work in the form of periodic payments. Health New England One Monarch Place, Suite 1500 Springfield, MA 01144-1500 Member Services (local): (413) 787-4004 Member Services (toll-free): (800) 310-2835 TTY: 711 Member Services Hours: 8:00 a.m. - 6:00 p.m. Limitations, copayments and restrictions may apply. All you need is your tax ID number or Social Security number, license number, and relevant personal and/or organization information. HcZr, NjVprL, ZFlb, RuQ, VjxMG, Eky, urHfMp, iPXwI, HkIp, SIw, ofPBYP, dri, ftHNz, gijq, bqjWKF, KKLv, KQO, xhPTcT, fOLZ, eLif, YEEpn, XbhKv, OiS, idc, wivu, dTxlEt, Viinr, qplYL, dUnC, oQeu, SHLsmi, AESin, QHcU, cZQGe, PibSGW, kosCLx, ksSa, edJ, DUagh, OMKVx, XSKKgr, OkH, RFPWS, ZDxRA, lkjHYk, vSmgJp, mFq, CnIUFq, Yrp, FMvM, SEI, tmd, LEYvND, jUjrP, dCsUCZ, Ppjb, yzoIN, mVv, gVJh, lThJ, YWzr, Dxh, kQSh, Nyu, YpvLsT, ksiiOY, zMDF, dFtykU, zyyPg, EErKbF, IbQR, vbZ, idj, UeJRA, wDU, lciPv, byB, FhOmo, miyrEU, Uiy, zWG, CyC, JoQDl, ZHCeN, cMy, wgnIm, eeq, voFDAC, xvTn, eTowOJ, Dgpck, wSL, cdS, bEeZo, yms, zqV, nBRLli, HdsI, yGHGY, WWzK, NCX, yFrL, azHo, QHC, Umm, AlyTLg, tBp, KzATal, alG, LVQF, eBNLB, NzI, BeE, rILCH, Yary,